Amy Beck

4.9k total citations · 1 hit paper
33 papers, 2.6k citations indexed

About

Amy Beck is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Amy Beck has authored 33 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 16 papers in Oncology and 8 papers in Immunology. Recurrent topics in Amy Beck's work include Immunotherapy and Immune Responses (7 papers), Peptidase Inhibition and Analysis (4 papers) and RNA modifications and cancer (4 papers). Amy Beck is often cited by papers focused on Immunotherapy and Immune Responses (7 papers), Peptidase Inhibition and Analysis (4 papers) and RNA modifications and cancer (4 papers). Amy Beck collaborates with scholars based in United States, Switzerland and France. Amy Beck's co-authors include Paulette Mhawech‐Fauceglia, Kunle Odunsi, Shashikant Lele, Feng Qian, Sacha Gnjatic, Lloyd J. Old, Junko Matsuzaki, Austin Miller, Protul Shrikant and Takemasa Tsuji and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Amy Beck

32 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor-infiltrating NY-ESO-1–specific CD8 ⁺ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer

2010 695 citations Junko Matsuzaki, Sacha Gnjatic et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amy Beck United States	21	1.3k	1.1k	1.1k	339	293	33	2.6k
Julie S. Nielsen Canada	20	927 0.7×	959 0.9×	686 0.6×	139 0.4×	207 0.7×	26	2.0k
Luca Zammataro Italy	18	665 0.5×	867 0.8×	1.2k 1.1×	201 0.6×	293 1.0×	39	2.4k
Stefania Canè Italy	23	698 0.5×	768 0.7×	619 0.6×	197 0.6×	310 1.1×	39	2.0k
Klara Balint United States	15	1.4k 1.0×	1.4k 1.3×	1.2k 1.1×	176 0.5×	454 1.5×	20	2.7k
Lalit R. Patel United States	18	1.1k 0.9×	451 0.4×	941 0.9×	430 1.3×	660 2.3×	26	2.3k
Elizabeth H. Stover United States	16	1.2k 0.9×	508 0.5×	1.2k 1.1×	333 1.0×	414 1.4×	46	2.7k
Håkan Hedman Sweden	28	601 0.5×	493 0.4×	1.5k 1.4×	188 0.6×	328 1.1×	71	2.3k
Anita Wolfer Switzerland	13	690 0.5×	454 0.4×	1.3k 1.3×	127 0.4×	352 1.2×	32	2.2k
Kazuhiro Kami Japan	20	1.0k 0.8×	272 0.2×	1.2k 1.1×	187 0.6×	320 1.1×	34	2.0k
Eleni Maniati United Kingdom	19	750 0.6×	708 0.6×	580 0.5×	155 0.5×	272 0.9×	40	1.6k

Countries citing papers authored by Amy Beck

Since Specialization

Citations

This map shows the geographic impact of Amy Beck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Beck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Beck more than expected).

Fields of papers citing papers by Amy Beck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Beck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Beck. The network helps show where Amy Beck may publish in the future.

Co-authorship network of co-authors of Amy Beck

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Beck. A scholar is included among the top collaborators of Amy Beck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Beck. Amy Beck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Odunsi, Kunle, Junko Matsuzaki, Smitha R. James, et al.. (2014). Epigenetic Potentiation of NY-ESO-1 Vaccine Therapy in Human Ovarian Cancer. Cancer Immunology Research. 2(1). 37–49. 153 indexed citations

Eng, Kevin H., Paulette Mhawech‐Fauceglia, Carl D. Morrison, et al.. (2014). Expression and Immune Responses to MAGE Antigens Predict Survival in Epithelial Ovarian Cancer. PLoS ONE. 9(8). e104099–e104099. 57 indexed citations

Liao, Jianqun, Feng Qian, Nana Tchabo, et al.. (2014). Ovarian Cancer Spheroid Cells with Stem Cell-Like Properties Contribute to Tumor Generation, Metastasis and Chemotherapy Resistance through Hypoxia-Resistant Metabolism. PLoS ONE. 9(1). e84941–e84941. 290 indexed citations

Godoy, Heidi, Paulette Mhawech‐Fauceglia, Amy Beck, et al.. (2013). Developmentally Restricted Differentiation Antigens Are Targets for Immunotherapy in Epithelial Ovarian Carcinoma. International Journal of Gynecological Pathology. 32(6). 536–540. 16 indexed citations

Odunsi, Kunle, Paulette Mhawech‐Fauceglia, Chris Andrews, et al.. (2012). Elevated Expression of the Serine-Arginine Protein Kinase 1 Gene in Ovarian Cancer and Its Role in Cisplatin Cytotoxicity In Vitro. PLoS ONE. 7(12). e51030–e51030. 40 indexed citations

Godoy, Heidi, Paulette Mhawech‐Fauceglia, Amy Beck, et al.. (2011). Expression of Poly (Adenosine Diphosphate-Ribose) Polymerase and p53 in Epithelial Ovarian Cancer and Their Role in Prognosis and Disease Outcome. International Journal of Gynecological Pathology. 0(0). 139–144. 19 indexed citations

Griffiths, Elizabeth A., Adam R. Karpf, Kunle Odunsi, et al.. (2011). Conventional Dose Hypomethylating Agents Induce CG Antigen Genes In Vivo. Blood. 118(21). 2441–2441. 1 indexed citations

Qian, Feng, Jeannine Villella, Paul K. Wallace, et al.. (2009). Efficacy of Levo-1-Methyl Tryptophan and Dextro-1-Methyl Tryptophan in Reversing Indoleamine-2,3-Dioxygenase–Mediated Arrest of T-Cell Proliferation in Human Epithelial Ovarian Cancer. Cancer Research. 69(13). 5498–5504. 118 indexed citations

Mhawech‐Fauceglia, Paulette, et al.. (2008). Association of TSC1/Hamartin, 14-3-3σ, and p27 Expression With Tumor Outcomes in Patients With pTa/pT1 Urothelial Bladder Carcinoma. American Journal of Clinical Pathology. 129(6). 918–923. 6 indexed citations

10.

Mhawech‐Fauceglia, Paulette, François R. Herrmann, Chris Andrews, et al.. (2008). 14-3-3σ Expression and prognostic value in patients with epithelial ovarian carcinoma: A high throughput tissue microarray analysis. European Journal of Surgical Oncology. 35(7). 763–767. 10 indexed citations

11.

Mhawech‐Fauceglia, Paulette, François R. Herrmann, Remedios Penetrante, et al.. (2006). Diagnostic utility of FLI‐1 monoclonal antibody and dual‐colour, break‐apart probe fluorescence in situ (FISH) analysis in Ewing's sarcoma/primitive neuroectodermal tumour (EWS/PNET). A comparative study with CD99 and FLI‐1 polyclonal antibodies. Histopathology. 49(6). 569–575. 61 indexed citations

12.

Mhawech‐Fauceglia, Paulette, Pavel Dulguerov, Amy Beck, Marta Bonet, & Abdelkarim S. Allal. (2006). Value of ezrin, maspin and nm23-H1 protein expressions in predicting outcome of patients with head and neck squamous-cell carcinoma treated with radical radiotherapy. Journal of Clinical Pathology. 60(2). 185–189. 26 indexed citations

13.

Mhawech‐Fauceglia, Paulette, et al.. (2006). FGFR3 and p53 protein expressions in patients with pTa and pT1 urothelial bladder cancer. European Journal of Surgical Oncology. 32(2). 231–237. 57 indexed citations

14.

Repasky, Elizabeth A., Protul Shrikant, Marilyn Intengan, et al.. (2005). Expression of Wilms tumor gene (WT1) in epithelial ovarian cancer. Gynecologic Oncology. 101(1). 12–17. 69 indexed citations

15.

Deeb, George, Jianmin Wang, Nithya Ramnath, et al.. (2004). Altered E-cadherin and epidermal growth factor receptor expressions are associated with patient survival in lung cancer: a study utilizing high-density tissue microarray and immunohistochemistry. Modern Pathology. 17(4). 430–439. 62 indexed citations

16.

Tan, Dongfeng, George Deeb, Jianmin Wang, et al.. (2003). HER-2/ neu Protein Expression and Gene Alteration in Stage I-IIIA Non???Small-Cell Lung Cancer: A Study of 140 Cases Using a Combination of High Throughput Tissue Microarray, Immunohistochemistry, and Fluorescent In Situ Hybridization. Diagnostic Molecular Pathology. 12(4). 201–211. 66 indexed citations

17.

Geel, Michel van, Amy Beck, Daniel J. Bolland, et al.. (2002). Genomic Analysis of Human Chromosome 10q and 4q Telomeres Suggests a Common Origin. Genomics. 79(2). 210–217. 105 indexed citations

18.

Geel, Michel van, Evan E. Eichler, Amy Beck, et al.. (2002). A Cascade of Complex Subtelomeric Duplications during the Evolution of the Hominoid and Old World Monkey Genomes. The American Journal of Human Genetics. 70(1). 269–278. 22 indexed citations

19.

Huberman, Joel A., Andrew Hyland, Gregory Loewen, et al.. (2001). MCM2 - a promising marker for premalignant lesions of the lung: a cohort study. BMC Cancer. 1(1). 6–6. 74 indexed citations

20.

Beck, Amy, M C Etienne, S. Chéradame, et al.. (1994). Wide range for optimal concentration of folinic acid in fluorouracil modulation—Experimental data on human tumour cell lines. European Journal of Cancer. 30(10). 1522–1526. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact